Plasma anti-BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer

Study of Novel Autoantibodies in Schizophrenia

(2018) Ruth Whelan et al.   SCHIZOPHRENIA BULLETIN

Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer

(2017) Pei Li et al.   TUMOR BIOLOGY

A hybrid solution for extracting structured medical information from unstructured data in medical records via a double-reading/entry system

(2016) Ligang Luo et al.   BMC Medical Informatics and Decision Making

A study of type-1 diabetes associated autoantibodies in schizophrenia

(2016) Philomena Hallford et al.   SCHIZOPHRENIA RESEARCH

Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status

(2015) I. Broodman et al.   Cancer Immunology Research

Study of circulating IgG antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancer

(2015) Yangchun Xu et al.   FEBS Open Bio

Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer

(2015) Leiguang Ye et al.   FEBS Open Bio

Development of a Multiplexed Tumor-Associated Autoantibody-Based Blood Test for the Detection of Non-Small Cell Lung Cancer

(2010) E. C. Farlow et al.   CLINICAL CANCER RESEARCH

Interleukin-18 promoter polymorphism is associated with lung cancer: A case-control study

(2009) Akbar Farjadfar et al.   ACTA ONCOLOGICA

Projected Cancer Risks From Computed Tomographic Scans Performed in the United States in 2007

(2009) Amy Berrington de González   ARCHIVES OF INTERNAL MEDICINE

Anti-survivin antibody responses in lung cancer

(2009) Vaios Karanikas et al.   CANCER LETTERS

Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer

(2009) Douglas D. Taylor et al.   GYNECOLOGIC ONCOLOGY

Small Cell Lung Cancer

(2009) Taimur Sher et al.   MAYO CLINIC PROCEEDINGS